Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

Diagnosis and Pathology: Understanding Your IMNM Report

At a Glance

Immune-Mediated Necrotizing Myopathy (IMNM) is diagnosed through markedly elevated Creatine Kinase (CK) blood levels and muscle biopsies showing active cell death (necrosis) with minimal inflammation. Diagnostic reports may also include MRI scans for muscle swelling and specific antibody tests.

Decoding your diagnostic reports is one of the most empowering steps you can take in managing Immune-Mediated Necrotizing Myopathy (IMNM). Because IMNM is often confused with other diseases, auditing your own labs and biopsy results ensures your care team is following the most current diagnostic standards, such as the 2016 ENMC criteria [1][2].

The Blood Work: Creatine Kinase (CK)

The most important number in your blood work is Creatine Kinase (CK). This is an enzyme that lives inside your muscles; when muscle fibers die, it leaks into your bloodstream [3].

  • The Signature of IMNM: For context, a normal CK level is typically under 200 U/L. In IMNM, it is often markedly elevated, reaching into the thousands or even tens of thousands of U/L [4][5].
  • Kidney Warning: When your CK is this high, the massive amount of dead muscle proteins can overwhelm your kidneys, a dangerous condition called rhabdomyolysis. If you see dark, tea-colored urine, seek emergency care immediately and ensure you stay highly hydrated [5].
  • Monitoring Tool: Your CK level acts like a “smoke detector” for your disease. As treatment begins to work and muscle death stops, your CK should begin to drop significantly [6][7].

The Muscle Biopsy: What to Look For

A muscle biopsy is a definitive way to see what is happening inside your tissue. In your pathology report, look for these specific terms:

  • Myofiber Necrosis: This is the hallmark of IMNM. It means the report shows active death of muscle cells [8][9].
  • Minimal Inflammatory Infiltration: This is the most “deceptive” part of IMNM. While other muscle diseases (like polymyositis) are packed with inflammatory cells, IMNM reports will often say there is very little inflammation relative to the amount of muscle death [10][11].
  • Regeneration: This is a positive sign! It means your body is actively trying to grow new muscle fibers to replace the ones that were lost [8][9].
  • p62 (SQSTM1): Doctors often use a special stain to look for this protein. In IMNM, p62 shows up as a “diffuse” stain throughout the muscle fiber, which helps confirm the diagnosis [11][12].
  • Membrane Attack Complex (MAC/C5b-9): Finding MAC deposits on the surface of your muscle fibers is a strong indicator of an immune-mediated attack [11][13].

Imaging and Electrical Tests

Beyond blood and tissue, your doctor may use two other specialized tests:

  1. MRI (STIR vs. T1): An MRI helps find which muscles are most affected. STIR sequences look for “edema” (swelling), which signals active disease [14]. T1 sequences look for “fatty replacement” or atrophy, which indicates older, permanent damage [15][16].
  2. Electromyography (EMG): This test measures the electrical activity of your muscles. An EMG for IMNM usually shows spontaneous electrical irritability (such as fibrillation potentials and positive sharp waves). While a rare finding called “electrical myotonia” can sometimes occur in IMNM, the absence of classic dive-bomber myotonia helps doctors rule out conditions like myotonic dystrophy [17].

Diagnosis Completeness Checklist

Use this checklist to ensure your diagnosis is comprehensive:

  • [ ] Antibody Test: Has a myositis-specific panel (including anti-SRP and anti-HMGCR) been performed? [1]
  • [ ] CK Trend: Is your CK being measured regularly to track treatment response? [6]
  • [ ] Biopsy Review: Does your report mention both necrosis and a lack of significant inflammation? [10]
  • [ ] Malignancy Screen: If you are seronegative, has a cancer screening been prioritized? [2]
  • [ ] Organ Check: Have your heart and lungs been evaluated, especially if you are anti-SRP positive? [18]

Common questions in this guide

What does a high Creatine Kinase (CK) level mean in IMNM?
Creatine kinase (CK) is an enzyme that leaks into your bloodstream when muscle fibers break down. In IMNM, CK levels are typically extremely high—often in the thousands—which indicates active, widespread muscle damage.
What will my muscle biopsy show if I have IMNM?
A classic IMNM muscle biopsy report will note active muscle cell death (myofiber necrosis) and signs of regeneration. Crucially, it will also show very little inflammation compared to other types of myositis.
Why do I need an MRI for a muscle disease?
An MRI helps doctors see which specific muscles are most affected. It can reveal active swelling (edema), which indicates ongoing disease activity, or fatty replacement, which points to older, permanent muscle damage.
Why is my urine dark or tea-colored with IMNM?
Dark or tea-colored urine is a medical emergency that can indicate rhabdomyolysis. This happens when massive amounts of dying muscle proteins enter the bloodstream and overwhelm your kidneys. You should seek emergency care immediately if you notice this symptom.
What specific blood tests and antibodies should I be checked for?
Your doctor should order a myositis-specific antibody panel that includes tests for anti-SRP and anti-HMGCR antibodies. Identifying these specific markers helps confirm your diagnosis and guides your treatment plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my biopsy show 'p62' staining or 'MAC/C5b-9' deposition on the muscle fibers?
  2. 2.How much 'minimal inflammation' was seen, and does this rule out polymyositis?
  3. 3.What was my peak Creatine Kinase (CK) level, and how quickly should we expect it to drop with treatment?
  4. 4.On my MRI, do you see signs of 'active edema' (STIR signal) or 'fatty replacement' (T1 signal)?
  5. 5.Did my EMG show spontaneous electrical irritability, and what does that mean for my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Peculiar clinicopathological features of immune-mediated necrotizing myopathies.

    Allenbach Y, Benveniste O

    Current opinion in rheumatology 2018; (30(6)):655-663 doi:10.1097/BOR.0000000000000547.

    PMID: 30239349
  2. 2

    Immune-mediated necrotizing myopathy: clinical features and pathogenesis.

    Allenbach Y, Benveniste O, Stenzel W, Boyer O

    Nature reviews. Rheumatology 2020; (16(12)):689-701 doi:10.1038/s41584-020-00515-9.

    PMID: 33093664
  3. 3

    [Two cases of statin-induced immune-mediated necrotizing myopathy].

    Safi T, Wagner H

    Lakartidningen 2021; (118()).

    PMID: 34861042
  4. 4

    When Statins Get Physical: A Curious Cause of Statin Myopathy.

    Patel PP, Jackson CD

    Southern medical journal 2022; (115(4)):266-269 doi:10.14423/SMJ.0000000000001379.

    PMID: 35365843
  5. 5

    Immune-Mediated Necrotizing Myopathy With Anti-3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) Antibodies Following Viral Infection and Without Association With Statin Use: A Case Report.

    Ferreira P, Dâmaso F, Anastácio M, et al.

    Cureus 2024; (16(9)):e70281 doi:10.7759/cureus.70281.

    PMID: 39463677
  6. 6

    A case of asymptomatic hyperCKemia for 40 years leading to a diagnosis of treatable immune-mediated necrotizing myopathy.

    Ishida R, Eura N, Nishimori Y, et al.

    Neuromuscular disorders : NMD 2025; (56-57()):106215 doi:10.1016/j.nmd.2025.106215.

    PMID: 41138436
  7. 7

    Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.

    Munekane A, Ohsawa Y, Okubo M, et al.

    Internal medicine (Tokyo, Japan) 2023; (62(9)):1345-1349 doi:10.2169/internalmedicine.0202-22.

    PMID: 36130887
  8. 8

    Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.

    Nicolau S, Milone M, Tracy JA, et al.

    Muscle & nerve 2021; (64(6)):734-739 doi:10.1002/mus.27435.

    PMID: 34617293
  9. 9

    Muscle RING finger-1 facilitates skeletal muscle regeneration via regulating myoblast proliferation and differentiation.

    Yang M, Ji S, Gao H, et al.

    Journal of translational medicine 2026; (24(1)).

    PMID: 41606616
  10. 10

    Statin-Induced Anti-HMGCR-Associated Myopathy.

    Basharat P, Lahouti AH, Paik JJ, et al.

    Journal of the American College of Cardiology 2016; (68(2)):234-5.

    PMID: 27386780
  11. 11

    Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.

    Merlonghi G, Antonini G, Garibaldi M

    Autoimmunity reviews 2022; (21(2)):102993 doi:10.1016/j.autrev.2021.102993.

    PMID: 34798316
  12. 12

    Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies.

    Fischer N, Preuße C, Radke J, et al.

    Brain pathology (Zurich, Switzerland) 2020; (30(2)):261-271 doi:10.1111/bpa.12772.

    PMID: 31376301
  13. 13

    [Clinical and pathological characteristics of immune mediated necrotizing myopathy].

    Yang HX, Tian XL, Jiang W, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2019; (51(6)):989-995.

    PMID: 31848492
  14. 14

    The Characteristics of Imaging Patterns on Whole-body Magnetic Resonance Imaging of Anti-signal Recognition Particle Antibody-positive Immune-mediated Necrotizing Myopathy.

    Hou YY, Huang WC, Huang CR, et al.

    Acta neurologica Taiwanica 2025; (34(4)):216-223 doi:10.4103/ANT.ANT_113_0054.

    PMID: 41467261
  15. 15

    Whole-body MRI and pathological findings in adult patients with myopathies.

    Tomas X, Milisenda JC, Garcia-Diez AI, et al.

    Skeletal radiology 2019; (48(5)):653-676 doi:10.1007/s00256-018-3107-1.

    PMID: 30377729
  16. 16

    Muscle imaging in myositis: MRI, US, and PET.

    Albayda J, Demonceau G, Carlier PG

    Best practice & research. Clinical rheumatology 2022; (36(2)):101765 doi:10.1016/j.berh.2022.101765.

    PMID: 35760742
  17. 17

    Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia.

    Triplett JD, Shelly S, Livne G, et al.

    Brain communications 2020; (2(2)):fcaa191 doi:10.1093/braincomms/fcaa191.

    PMID: 33364599
  18. 18

    Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.

    Anquetil C, Boyer O, Wesner N, et al.

    Autoimmunity reviews 2019; (18(3)):223-230 doi:10.1016/j.autrev.2018.09.008.

    PMID: 30639649

This page is for informational purposes only and is designed to help you understand medical terms commonly found in IMNM diagnostic reports. It does not replace professional medical advice or interpretation by your neurologist or rheumatologist.

Get notified when new evidence is published on Immune-mediated necrotizing myopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.